|
|
|
Volumn 6, Issue 2, 2013, Pages 169-179
|
|
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ATORVASTATIN;
CLOPIDOGREL;
CYP2C19 PROTEIN, HUMAN;
DRUG DERIVATIVE;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
P2RY12 PROTEIN, HUMAN;
PURINERGIC P2Y RECEPTOR ANTAGONIST;
PURINERGIC P2Y12 RECEPTOR;
PYRROLE DERIVATIVE;
TICLOPIDINE;
UNSPECIFIC MONOOXYGENASE;
AGE;
AGED;
ARTICLE;
BLOOD;
BLOOD CLOTTING PARAMETERS;
CHI SQUARE DISTRIBUTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG EFFECT;
DRUG INTERACTION;
DRUG RESISTANCE;
FEMALE;
GENETICS;
HUMAN;
ITALY;
MALE;
METABOLISM;
MIDDLE AGED;
PERCUTANEOUS CORONARY INTERVENTION;
PHARMACOGENETICS;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK;
RISK ASSESSMENT;
RISK FACTOR;
THROMBOCYTE;
TIME;
TREATMENT OUTCOME;
VERY ELDERLY;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ARYL HYDROCARBON HYDROXYLASES;
BLOOD PLATELETS;
CHI-SQUARE DISTRIBUTION;
CORONARY ARTERY DISEASE;
DRUG INTERACTIONS;
DRUG RESISTANCE;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
ITALY;
MALE;
MIDDLE AGED;
ODDS RATIO;
PERCUTANEOUS CORONARY INTERVENTION;
PHARMACOGENETICS;
PLATELET AGGREGATION INHIBITORS;
PLATELET FUNCTION TESTS;
PROSPECTIVE STUDIES;
PURINERGIC P2Y RECEPTOR ANTAGONISTS;
PYRROLES;
RECEPTORS, PURINERGIC P2Y12;
RISK ASSESSMENT;
RISK FACTORS;
TICLOPIDINE;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84877728751
PISSN: None
EISSN: 18767605
Source Type: None
DOI: None Document Type: Article |
|
Times cited : (27)
|
|
References (0)
|
